Scot Michael Elder Treace Medical Concepts, Inc. (TMCI) insider trading activity

Scot Michael Elder is Chief Legl & Comp Off, CorpSec of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 548,281 shares of TMCI, which is worth approximately $1.66 Million. The most recent transaction as insider was on Oct 25, 2025, when has been sold 984 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 548K

3.16% 3M change

21.93% 12M change

Total Value Held $1.66 Million

Scot Michael Elder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 25 2025	SELL Payment of exercise price or tax liability	-	984 Reduced 0.18%	548,281 Common Stock
Oct 02 2025	SELL Payment of exercise price or tax liability	-	650 Reduced 0.12%	549,265 Common Stock
Sep 30 2025	SELL Payment of exercise price or tax liability	-	16,234 Reduced 2.87%	549,915 Common Stock
Aug 09 2025	SELL Payment of exercise price or tax liability	-	10,515 Reduced 1.82%	566,149 Common Stock
May 08 2025	SELL Payment of exercise price or tax liability	$14,280 $7.54 p/Share	1,894 Reduced 0.33%	576,664 Common Stock
May 08 2025	BUY Grant, award, or other acquisition	-	7,775 Added 1.33%	578,558 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	-	1,675 Reduced 0.29%	570,783 Common Stock
Mar 08 2025	SELL Payment of exercise price or tax liability	-	176 Reduced 0.03%	572,458 Common Stock
Jan 22 2025	BUY Grant, award, or other acquisition	-	127,500 Added 18.21%	572,634 Common Stock
Jan 10 2025	SELL Payment of exercise price or tax liability	-	4,544 Reduced 1.01%	445,134 Common Stock
Nov 11 2024	SELL Payment of exercise price or tax liability	$31,394 $8.29 p/Share	3,787 Reduced 0.84%	449,678 Common Stock
Nov 11 2024	BUY Grant, award, or other acquisition	-	15,550 Added 3.31%	453,654 Common Stock
Sep 30 2024	BUY Grant, award, or other acquisition	-	200,000 Added 31.35%	437,915 Common Stock
Aug 09 2024	BUY Grant, award, or other acquisition	-	129,540 Added 35.25%	237,915 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	-	1,666 Reduced 1.51%	108,375 Common Stock
Mar 08 2024	SELL Payment of exercise price or tax liability	-	169 Reduced 0.15%	110,041 Common Stock
Jan 10 2024	BUY Grant, award, or other acquisition	-	61,300 Added 35.74%	110,210 Common Stock
Nov 02 2023	SELL Payment of exercise price or tax liability	-	609 Reduced 1.23%	48,910 Common Stock
Oct 03 2023	SELL Payment of exercise price or tax liability	-	402 Reduced 0.81%	49,519 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	27,500 Added 35.52%	49,921 Common Stock
Mar 09 2023	SELL Open market or private sale	$4,320 $24.41 p/Share	177 Reduced 0.78%	22,421 Common Stock
Nov 17 2022	SELL Open market or private purchase	$80,249 $21.48 p/Share	3,736 Reduced 14.19%	22,598 Common Stock
Oct 26 2022	SELL Open market or private sale	$14,380 $23.46 p/Share	613 Reduced 3.15%	18,862 Common Stock
Oct 01 2022	BUY Grant, award, or other acquisition	-	6,600 Added 25.31%	19,475 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	2,875 Added 18.25%	12,875 Common Stock

SME

Scot Michael Elder

Chief Legl & Comp Off, CorpSec

Ponte Vedra, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMCI shares.

Notify only if

Value

Insider Trading

Get notified when an Treace Medical Concepts, Inc. insider buys or sells TMCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to TREACE MEDICAL CONCEPTS, INC.

Track Activities on TMCI

Account